Literature DB >> 17118326

Ultraviolet fluorescence photography: patterns in established pterygia.

Ju-Lee Ooi1, Neil S Sharma, Shanel Sharma, Daya Papalkar, Mike Oakey, Pamela Dawes, Minas T Coroneo.   

Abstract

PURPOSE: To investigate established pterygia using our newly developed ultraviolet fluorescence photography (UVFP) system.
DESIGN: Prospective observational case series.
METHODS: setting: Prince of Wales Hospital, Sydney, Australia. study population: Fourteen patients (both eyes) attending the Ophthalmology Clinic at Prince of Wales Hospital for assessment of their established pterygia. There were eight men and six women, with an age range of 26 to 62 years. A total of 15 (75%) of 20 had primary pterygia, and five (25%) of 20 had recurrent pterygia. There were no specific exclusion criteria. observation procedures: Ultraviolet and standard (control) photographs were taken of the nasal and temporal interpalpebral regions bilaterally. main outcome measures: The presence of established pterygia detected by standard photography and the corresponding presence and patterns of areas of fluorescence detected by UVFP.
RESULTS: In the 14 patients, 20 established pterygia were identified on standard photography. On UVFP, four patterns of fluorescence of established pterygia were identified. Of the 20 pterygia, six (30%) of 20 demonstrated fluorescence at the leading edge of the pterygium, seven (35%) of 20 demonstrated fluorescence at the limbus, three (15%) of 20 demonstrated fluorescence at both the leading edge and the limbus, and four (20%) of 20 demonstrated no visible fluorescence.
CONCLUSIONS: In this study, we describe patterns of fluorescence in established pterygia by UVFP. We hypothesize that the areas of fluorescence represent areas of cellular activity within the pterygium. The patterns of fluorescence may be useful to further understand of pterygium growth and pathogenesis.

Entities:  

Mesh:

Year:  2006        PMID: 17118326     DOI: 10.1016/j.ajo.2006.08.028

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  7 in total

1.  Distribution of conjunctival ultraviolet autofluorescence in a population-based study: the Norfolk Island Eye Study.

Authors:  J C Sherwin; A W Hewitt; L S Kearns; M T Coroneo; L R Griffiths; D A Mackey
Journal:  Eye (Lond)       Date:  2011-04-15       Impact factor: 3.775

Review 2.  The measurement of time spent outdoors in child myopia research: a systematic review.

Authors:  Jing Wang; Xian-Gui He; Xun Xu
Journal:  Int J Ophthalmol       Date:  2018-06-18       Impact factor: 1.779

3.  Quantification of sun-related changes in the eye in conjunctival ultraviolet autofluorescence images.

Authors:  Emily Huynh; Danuta M Bukowska; Seyhan Yazar; Charlotte M McKnight; Ajmal Mian; David A Mackey
Journal:  J Med Imaging (Bellingham)       Date:  2016-08-05

4.  Seasonal Effect on Ocular Sun Exposure and Conjunctival UV Autofluorescence.

Authors:  Kristina M Haworth; Heather L Chandler
Journal:  Optom Vis Sci       Date:  2017-02       Impact factor: 1.973

5.  Genetic and environmental factors in conjunctival UV autofluorescence.

Authors:  Seyhan Yazar; Gabriel Cuellar-Partida; Charlotte M McKnight; Piriya Quach-Thanissorn; Jenny A Mountain; Minas T Coroneo; Craig E Pennell; Alex W Hewitt; Stuart MacGregor; David A Mackey
Journal:  JAMA Ophthalmol       Date:  2015-04       Impact factor: 7.389

6.  Twins eye study in Tasmania (TEST): rationale and methodology to recruit and examine twins.

Authors:  David A Mackey; Jane R Mackinnon; Shayne A Brown; Lisa S Kearns; Jonathan B Ruddle; Paul G Sanfilippo; Cong Sun; Christopher J Hammond; Terri L Young; Nicholas G Martin; Alex W Hewitt
Journal:  Twin Res Hum Genet       Date:  2009-10       Impact factor: 1.587

7.  Associations Between Fetal Growth Trajectories and the Development of Myopia by 20 Years of Age.

Authors:  Kathleen I C Dyer; Paul G Sanfilippo; Scott W White; Jeremy A Guggenheim; Chris J Hammond; John P Newnham; David A Mackey; Seyhan Yazar
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-12-01       Impact factor: 4.799

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.